Literature DB >> 11893684

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.

Jane H Morse1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893684     DOI: 10.1378/chest.121.3_suppl.50s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

1.  Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy.

Authors:  Sarah Michelman Lo; Jun Liu; F Chen; G M Pastores; J Knowles; M Boxer; Kirk Aleck; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2011-03-29       Impact factor: 4.982

2.  Increased Methyl-CpG-Binding Domain Protein 2 Promotes Cigarette Smoke-Induced Pulmonary Hypertension.

Authors:  Jixing Wu; Qian Huang; Qinghai Li; Yiya Gu; Yuan Zhan; Ting Wang; Jinkun Chen; Zhilin Zeng; Yongman Lv; Jianping Zhao; Jie Xia; Jungang Xie
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

3.  BMPER is a conserved regulator of hematopoietic and vascular development in zebrafish.

Authors:  Martin Moser; Qingming Yu; Christoph Bode; Jing-Wei Xiong; Cam Patterson
Journal:  J Mol Cell Cardiol       Date:  2007-05-18       Impact factor: 5.000

4.  Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension.

Authors:  Silvia Ulrich; Martin Hersberger; Manuel Fischler; Lars C Huber; Oliver Senn; Ursula Treder; Rudolf Speich; Christoph Schmid
Journal:  Open Respir Med J       Date:  2009-04-14

5.  The Efficacy of a Genetic Analysis of the BMPR2 Gene in a Patient with Severe Pulmonary Arterial Hypertension and an Atrial Septal Defect Treated with Bilateral Lung Transplantation.

Authors:  Shunsuke Tatebe; Koichiro Sugimura; Tatsuo Aoki; Saori Yamamoto; Nobuhiro Yaoita; Hideaki Suzuki; Haruka Sato; Katsuya Kozu; Ryo Konno; Kimio Satoh; Koji Fukuda; Osamu Adachi; Ryoko Saito; Norifumi Nakanishi; Hiroko Morisaki; Kotaro Oyama; Yoshikatsu Saiki; Yoshinori Okada; Hiroaki Shimokawa
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.